Kinetics of the Solution-Mediated Polymorphic Transformation of Organic Compounds

被引：7
|
作者：
Wantha, Lek [1 ]
机构：
[1] Burapha Univ, Fac Engn, Dept Chem Engn, 169 Long Hard Bangsaen Rd, Chon Buri 20131, Thailand
来源：
CURRENT PHARMACEUTICAL DESIGN | 2018年 / 24卷 / 21期
关键词：
Polymorphism; organic compound; crystallization from solution; kinetics; solution-mediated polymorphic transformation; process modelling; L-GLUTAMIC ACID; ACTIVE PHARMACEUTICAL INGREDIENTS; POPULATION BALANCE MODEL; DRUG-DELIVERY SYSTEM; FORM III PIRACETAM; SOLID-STATE; NUCLEATION KINETICS; CRYSTALLIZATION BEHAVIOR; DISSOLUTION KINETICS; PHASE-TRANSFORMATION;
D O I：
10.2174/1381612824666180601093228
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Polymorphism is a behavior of a substance to crystallize into more than one district crystal structures. Preferential formation of a polymorph depends strongly on the kinetics of the relevant mechanisms. Solution-mediated polymorphic transformation is an important mechanism in crystallization of organic compounds from solution. Knowing its kinetics allows us to understand the process and control the polymorphic formation. In this review, concepts, kinetics, and process modeling of crystallization and solution-mediated polymorphic transformation are examined and summarized.
引用
收藏
页码：2383 / 2393
页数：11
相关论文
共 50 条
  • [1] Solution-Mediated Polymorphic Transformation of FV Sulphathiazole
    Munroe, Aine
    Croker, Denise M.
    Rasmuson, Ake C.
    Hodnett, Benjamin K.
    CRYSTAL GROWTH & DESIGN, 2014, 14 (07) : 3466 - 3471
  • [2] SOLUTION-MEDIATED POLYMORPHIC TRANSFORMATION OF STEARIC-ACID
    WELLNER, E
    GARTI, N
    SARIG, S
    CRYSTAL RESEARCH AND TECHNOLOGY, 1981, 16 (11) : 1283 - 1288
  • [3] Crystallization in polymorphic systems:: The solution-mediated transformation β to α glycine
    Ferrari, ES
    Davey, RJ
    Cross, WI
    Gillon, AL
    Towler, CS
    CRYSTAL GROWTH & DESIGN, 2003, 3 (01) : 53 - 60
  • [4] Solid-State and Solution-Mediated Polymorphic Transformation of Rifampicin
    Jing, Dingding
    Gu, Yuan
    Xia, Huiming
    CHEMICAL ENGINEERING & TECHNOLOGY, 2018, 41 (06) : 1236 - 1243
  • [5] Solution-Mediated Polymorphic Transformation: Form II to Form III Piracetam in Organic Solvents
    Maher, Anthony
    Croker, Denise M.
    Seaton, Colin C.
    Rasmuson, Ake C.
    Hodnett, Benjamin K.
    CRYSTAL GROWTH & DESIGN, 2014, 14 (08) : 3967 - 3974
  • [6] Response surface analysis of solution-mediated polymorphic transformation of buspirone hydrochloride
    Sheikhzadeh, A.
    Murad, S.
    Rohani, S.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 45 (02) : 227 - 236
  • [7] Influence Factor Investigation on the Solution-Mediated Polymorphic Transformation of Baricitinib Phosphate
    Hong, Minghuang
    Guo, Sai
    Wang, Kai
    Ma, Lei
    Ren, Guobin
    ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE, 2018, 644 (15): : 849 - 855
  • [8] Examining Solution and Solid State Composition for the Solution-Mediated Polymorphic Transformation of Carbamazepine and Piracetam
    O'Mahony, Marcus A.
    Maher, Anthony
    Croker, Denise M.
    Rasmuson, Ake C.
    Hodnett, Benjamin K.
    CRYSTAL GROWTH & DESIGN, 2012, 12 (04) : 1925 - 1932
  • [9] Influence of Solvents on Solution-Mediated Polymorphic Transformation of the Polymorphs of L-Histidine
    Wantha, Lek
    Punmalee, Neeranuch
    Flood, Adrian E.
    CHEMICAL ENGINEERING & TECHNOLOGY, 2019, 42 (07) : 1505 - 1511
  • [10] Kinetics of the Solution-Mediated Polymorphic Transformation of the Novel L-Carnitine Orotate Polymorph, Form-II
    An, Ji-Hun
    Youn, Wonno
    Kiyonga, Alice Nguvoko
    Lim, Changjin
    Park, Minho
    Suh, Young-Ger
    Ryu, Hyung Chul
    Kim, Jae Sun
    Park, Chun-Woong
    Jung, Kiwon
    PHARMACEUTICS, 2018, 10 (04):
12345